MeSH tree: C04.557.470.200.025
University of California, San Francisco investigators led WISDOM, a randomized comparison of risk-based breast cancer screening and annual mammography. Rates of stage ≥IIB breast cancers met a noninferiority threshold under ...
Scientists have identified a promising strategy to improve liver cancer immunotherapy: targeting B-cells. While immunotherapy has transformed cancer treatment by activating T-cells—a type of immune cell that fights cancerous ...
Dec 15, 2025
0
15
Providers are reeling from a change made by a federal agency responsible for setting and updating vaccination guidelines for American children and adults.
Dec 12, 2025
0
12
Using lung cancer biospecimens from the Sherlock-Lung study, an international team led by National Institutes of Health (NIH) researchers, identified key factors that drive tumor evolution and influence outcomes. Overall, ...
Dec 10, 2025
0
25
Hepatitis delta virus (HDV), a bloodborne infection that is transmitted through infected blood or other bodily fluids, was recently designated as a Group 1 carcinogen by the International Agency for Research on Cancer (IARC). ...
Dec 10, 2025
0
9
It's normal for parents, or anyone, to have questions about vaccinations—but what happens if your pediatrician urges a shot that's under attack by the Trump administration?
Dec 10, 2025
0
11
On Dec. 5, the Committee on Immunization Practices voted to approve new recommendations delaying the child hepatitis B vaccine for infants, providing a win for the Make America Healthy Again movement while troubling many ...
Dec 8, 2025
0
13
Prevention and treatment advances are reducing the number of new liver cancer patients and narrowing survival gaps among racial groups, a Cedars-Sinai Cancer study published in the journal Clinical Gastroenterology and Hepatology ...
Dec 8, 2025
0
16
A federal vaccine advisory committee voted on Friday to end the longstanding recommendation that all U.S. babies get the hepatitis B vaccine on the day they're born.
Dec 5, 2025
0
11
A federal vaccine advisory committee has voted to change a long-standing recommendation that all newborns in the United States receive the hepatitis B vaccine on the day they are born.
Dec 5, 2025
0
16
